Market News AIOpen the app

Redhill Biopharma's shares surge 100% in a single day following Talicia sale to Apotex for $18 million.

MarketRead the original at benzinga.com
Good for RDHL

The Talicia divestment provides immediate cash and milestone potential that materially improves liquidity and funds Redhill's commercial expansion, while pipeline progress adds further upside.

RDHL · Redhill Biopharma Ltd.

AI read · Good for RDHL

The AI's read

The Talicia divestment to Apotex produces an immediate, material cash infusion ($18M upfront) and milestone upside that meaningfully strengthens Redhill's liquidity and funds its planned commercial expansion; combined with ongoing RHB-102 development progress, the net effect in the source is positive. The trade-off—converting a 70% stake into cash—reduces ownership of an existing product but preserves milestone-based upside, and the company frames the move as central to its strategic roadmap.

Get alerts for RDHL

Follow Redhill Biopharma Ltd. (RDHL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RDHL
Free on the App Store and Google Play, or on the web.